SCHEMBL19600350

SCHEMBL19600350

CC(C)(C)OC(=O)Nc1ccc(C(=O)N[C@H]2CCC[C@@H](Nc3cc(C4=CCc5ccccc54)c(Cl)cn3)C2)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CDK7 P50613 5/20 0.42
▸ CDK9 P50750 8/20 0.41
▸ CCNT1 O60563 6/20 0.41
▸ CCNK O75909 2/20 0.41
▸ CCNH P51946 2/20 0.41
▸ MNAT1 P51948 2/20 0.41
▸ CDK12 Q9NYV4 2/20 0.41
▸ NAMPT P43490 2/20 0.36
▸ GRM5 P41594 2/20 0.36
▸ MAPK1 P28482 1/20 0.35
▸ IDO1 P14902 1/20 0.35
▸ BTK Q06187 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ CDK4 P11802 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ AXL P30530 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18069788 0.88 CDK7 (0.53) CDK7CDK9CCNT1CCNKCCNH
SCHEMBL18069797 0.81 CDK7 (0.45) CDK7CDK9CCNT1CCNKCCNH
SCHEMBL18069762 0.80 CDK7 (0.50) CDK7CDK9CCNT1CCNKCCNH
SCHEMBL18069775 0.79 CDK7 (0.42) CDK7CDK9CCNT1CCNKCCNH
SCHEMBL18069767 0.79 CDK7 (0.50) CDK7CDK9CCNT1CCNKCCNH
SCHEMBL19580253 0.78 CDK9 (0.42) CDK7CDK9CCNT1CCNKCCNH
SCHEMBL17688424 0.78 CDK9 (0.42) CDK7CDK9CCNT1CCNKCCNH
SCHEMBL19600349 0.77 CCNT1 (0.49) CDK9CCNT1CDK4
SCHEMBL18069752 0.76 CDK7 (0.42) CDK7CDK9CCNT1CCNKCCNH
SCHEMBL19600316 0.76 CDK7 (0.42) CDK7CDK9CCNT1CCNKCCNH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170327496-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) OXFORD FINANCE LLC, AS COLLATERAL AGENT 2017-11-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327496-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) CDK7, CDK3, CDK9 CDK7 1/4885CDK9 3/4885CCNT1 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback